A dataset profiling the multiomic landscape of the prefrontal cortex in amyotrophic lateral sclerosis
2024

Multiomic Analysis of the Prefrontal Cortex in ALS

Sample size: 101 publication 10 minutes Evidence: high

Author Information

Author(s): Hausmann Fabian, Caldi Gomes Lucas, Hänzelmann Sonja, Khatri Robin, Oller Sergio, Gebelin Marie, Parvaz Mojan, Tzeplaeff Laura, Pasetto Laura, Zhou Qihui, Zelina Pavol, Edbauer Dieter, Pasterkamp R Jeroen, Rehrauer Hubert, Schlapbach Ralph, Carapito Christine, Bonetto Valentina, Bonn Stefan, Lingor Paul

Primary Institution: University Medical Center Hamburg-Eppendorf

Hypothesis

What are the early molecular changes in the prefrontal cortex of patients with amyotrophic lateral sclerosis (ALS)?

Conclusion

The study provides a comprehensive multiomic dataset that reveals distinct molecular subclusters in ALS patients, highlighting sex differences and potential therapeutic targets.

Supporting Evidence

  • The study identified distinct molecular subclusters within ALS patients, suggesting different underlying disease mechanisms.
  • Sex differences were observed in the molecular profiles, with male patients showing more pronounced alterations.
  • The MAPK pathway was highlighted as a critical therapeutic target for ALS.
  • Data from ALS mouse models corroborated the findings from human analyses.
  • The dataset is designed to be findable, accessible, interoperable, and reproducible (FAIR).
  • Comprehensive documentation of bioinformatics methodologies was provided to facilitate reproducibility.
  • Ethical approval was obtained for all human and animal studies involved in the research.
  • The study emphasizes the importance of early disease mechanisms in understanding ALS pathology.

Takeaway

Researchers looked at brain samples from people with ALS to find out what changes happen early in the disease, which could help in finding new treatments.

Methodology

The study involved multiomic analysis of human postmortem prefrontal cortex tissue from 51 ALS patients and 50 control subjects, along with data from 4 ALS mouse models.

Potential Biases

Potential biases may arise from the selection of brain banks and the inherent variability in postmortem tissue.

Limitations

The study primarily focuses on postmortem samples, which may not fully capture the dynamic changes occurring during disease progression.

Participant Demographics

The human cohort included 51 patients with sporadic ALS (16 females, 35 males) and 50 control subjects (28 females, 22 males), with ages ranging from 43 to 94 years.

Digital Object Identifier (DOI)

10.1093/gigascience/giae100

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication